143 related articles for article (PubMed ID: 17006909)
1. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
Fontana RJ; Kleiner DE; Bilonick R; Terrault N; Afdhal N; Belle SH; Jeffers LJ; Ramcharran D; Ghany MG; Hoofnagle JH;
Hepatology; 2006 Oct; 44(4):925-35. PubMed ID: 17006909
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.
Aslinia FM; Wasan SK; Mindikoglu AL; Adeyemo OA; Philosophe B; Drachenberg C; Howell CD
J Viral Hepat; 2012 May; 19(5):371-6. PubMed ID: 22497817
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.
Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ
J Viral Hepat; 2011 Apr; 18(4):e144-52. PubMed ID: 21070504
[TBL] [Abstract][Full Text] [Related]
4. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.
Howell CD; Dowling TC; Paul M; Wahed AS; Terrault NA; Taylor M; Jeffers L; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2008 May; 6(5):575-83. PubMed ID: 18407798
[TBL] [Abstract][Full Text] [Related]
5. Race, insulin resistance and hepatic steatosis in chronic hepatitis C.
Conjeevaram HS; Kleiner DE; Everhart JE; Hoofnagle JH; Zacks S; Afdhal NH; Wahed AS;
Hepatology; 2007 Jan; 45(1):80-7. PubMed ID: 17187406
[TBL] [Abstract][Full Text] [Related]
6. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients.
Johansson S; Talloen W; Tuefferd M; Darling JM; Scholliers A; Fanning G; Fried MW; Aerssens J
Aliment Pharmacol Ther; 2015 Nov; 42(9):1111-21. PubMed ID: 26314558
[TBL] [Abstract][Full Text] [Related]
8. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
11. Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter?
Kohla M; Iwata S; Ea R; Keyhan S; Taylor R; Yu MC; Groshen S; Bonacini M
Dig Dis Sci; 2012 Mar; 57(3):771-6. PubMed ID: 21948357
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans.
Sterling RK; Stravitz RT; Luketic VA; Sanyal AJ; Contos MJ; Mills AS; Shiffman ML
Clin Gastroenterol Hepatol; 2004 Jun; 2(6):469-73. PubMed ID: 15181614
[TBL] [Abstract][Full Text] [Related]
13. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.
Conjeevaram HS; Fried MW; Jeffers LJ; Terrault NA; Wiley-Lucas TE; Afdhal N; Brown RS; Belle SH; Hoofnagle JH; Kleiner DE; Howell CD;
Gastroenterology; 2006 Aug; 131(2):470-7. PubMed ID: 16890601
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C.
Crosse K; Umeadi OG; Anania FA; Laurin J; Papadimitriou J; Drachenberg C; Howell CD
Clin Gastroenterol Hepatol; 2004 Jun; 2(6):463-8. PubMed ID: 15181613
[TBL] [Abstract][Full Text] [Related]
15. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.
Hoofnagle JH; Wahed AS; Brown RS; Howell CD; Belle SH;
J Infect Dis; 2009 Apr; 199(8):1112-20. PubMed ID: 19284286
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.
Gordon SC; Lamerato LE; Rupp LB; Holmberg SD; Moorman AC; Spradling PR; Teshale E; Xu F; Boscarino JA; Vijayadeva V; Schmidt MA; Oja-Tebbe N; Lu M
Am J Gastroenterol; 2015 Aug; 110(8):1169-77; quiz 1178. PubMed ID: 26215529
[TBL] [Abstract][Full Text] [Related]
17. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
18. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.
Bonnard P; Elsharkawy A; Zalata K; Delarocque-Astagneau E; Biard L; Le Fouler L; Hassan AB; Abdel-Hamid M; El-Daly M; Gamal ME; El Kassas M; Bedossa P; Carrat F; Fontanet A; Esmat G
J Viral Hepat; 2015 Mar; 22(3):245-53. PubMed ID: 25073725
[TBL] [Abstract][Full Text] [Related]
19. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Rosario P; Mormone G; Ragone E; Pasquale G; Ruggiero G
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):299-304. PubMed ID: 10750650
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
